Skip to content
HS INsight Logo
  • What We Do
    • For Providers
      • Model-Informed Precision Dosing
      • Clinical Decision Support
      • Real-Time Clinical Analytics
      • Infectious Disease
      • Bone Marrow Transplant
      • Other Therapeutic Areas
      • Customers
    • For Life Sciences
      • Precision Dosing in Clinical Trials
      • Real-time Pharmacology Analytics in Clinical Trials
      • Companion Applications
  • How We Do It
    • InsightRX Nova
    • InsightRX Apollo
    • Continuous Learning
    • Integrations
    • Drug Modules
    • Security
  • Company
    • Mission & Values
    • Leadership
    • Careers
  • Press Releases
    • Press Releases
    • Media
  • Resources
    • Product Innovation
    • Scientific Publications
    • Thought Leadership
    • White Papers
  • Contact Us
73ef87d2-366a-4ff5-be0e-909a0b7654a2

FEATURED

Beyond Vancomycin: Why Linezolid & Daptomycin Call for Precision Dosing

Read More
Resources
Product Innovation
  • Mar 11, 2022
  • 2021 Year in Review and Recent Product Enhancements

    Thought Leadership
  • Jan 11, 2022
  • The Role Of The Democratized Research Network In Optimizing Precision Dosing

    Scientific Publications
  • Jul 17, 2021
  • A Hybrid Machine Learning/Pharmacokinetic Approach Outperforms Maximum a Posteriori Bayesian Estimation by Selectively Flattening Model Priors

    Scientific Publications
  • Apr 17, 2021
  • Model-Based Estimation of Iohexol Plasma Clearance for Pragmatic Renal Function Determination in the Renal Transplantation Setting

    Scientific Publications
  • Mar 30, 2021
  • Population Pharmacokinetics and Genetics of Oral Meltdose Tacrolimus (Envarsus) in Stable Adult Liver Transplant Recipients

    Scientific Publications
  • Mar 1, 2021
  • The Relationship Between Busulfan Exposure and Achievement of Sustained Donor Myeloid Chimerism in Patients with Non-Malignant Disorders

    Scientific Publications
  • Oct 17, 2020
  • Continuous Learning in Model-Informed Precision Dosing: A Case Study in Pediatric Dosing of Vancomycin

    Scientific Publications
  • Aug 18, 2020
  • Mathematical model and tool to explore shorter multi-drug therapy options for active pulmonary tuberculosis

    Scientific Publications
  • Aug 1, 2020
  • The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse

    4 5 6 7 8
    WHAT WE DO

    For Providers
    • Model-Informed Precision Dosing
    • Dosing Decision Support
    • Real-Time Dosing Analytics
    For Life Sciences
    • Precision Dosing in Clinical Trials
    • Real-Time Pharmacology Analytics in Clinical Trials
    • Companion Applications
    HOW WE DO IT

    • InsightRX Nova
    • InsightRX Apollo
    • Continuous Learning
    • Integrations
    • Drug Modules
    • Security
    • Product Innovation
    COMPANY

    • Leadership
    • News
    • Resources
    • Careers
    • Citing InsightRX
    • In The News
    • Press Releases
    • Media
    • Scientific Publications
    • Thought Leadership
    • White Papers

    HS INsight Logo
    CE Mark-001

    InsightRX Nova is not considered to be a medical device in the U.S. and has not been submitted to the U.S. Food and Drug Administration for review or clearance.

    Copyright © 2024 InsightRX, Inc.
    740-05000-REC-01 03/2022

    Follow us on LinkedIn Follow us on Twitter

    WHERE WE ARE

    548 Market St #88083, San Francisco, CA 94104
    Privacy Policy